Geneservice Appoints Non-Executive Chairman
News Feb 02, 2006
Geneservice Ltd has announced that the Board of Directors has appointed Dr Andy Richards as non-executive Chairman.
He is a director of the UK Bioindustry Association and this year was voted both Cambridge Evening News Businessman of the Year as well as one of the Top100 Living Contributors to Biotechnology.
This new appointment follows on from the management buyout of Geneservice from the UK MRC in August 2005.
On his appointment to the board of Geneservice Dr Richards said, "Geneservice have already demonstrated that they have real potential to develop into a major provider of specialist high quality contract research and reagents to the life sciences and rapidly growing biotechnology industry."
"The strong and committed team that led the management buyout have ambitious plans to grow Geneservice and I am delighted to have the opportunity to help them achieve this."
CEO of Geneservice Dr Tom Weaver added, "We are a young company and our aim was to bring in someone with extensive knowledge of biotechnology and experience with small startup companies."
"Andy’s expertise and networking ability is exactly what we need at this stage of our development, plus he shares our vision to rapidly build up our product and service portfolio."
"His infectious passion for innovation and getting the most out of our people, operations and business opportunities will add so much to our senior management team."
New Inherited Neurodevelopmental Disease DiscoveredNews
Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.READ MORE
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE